Australia NRT Smoking Cessation Aids Market Report: Trends, Growth and Forecast (2026-2032)
By Category (NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT Products), By Gender (Male, Female), By Sales Channel (Retail Online (Online Pharmacies, Brand-Owned Websites, E-commerce Marketplaces), Retail Offline (Hospital, Pharmacies, Drug Stores)), By End User (Individual / Consumer Self-Use, Healthcare-Professional-Supervised (Clinics, De-addiction Centers, Smoking Cessation Centers)), By Region (Queensland, New South Wales, Victoria, South Australia, Others) ... Read more
|
Major Players
|
Australia NRT Smoking Cessation Aids Market Statistics and Insights, 2026
- Market Size Statistics
- Nrt smoking cessation aids market size in Australia was valued at USD 140 million in 2025 and is estimated at USD 145 million in 2026.
- The market size is expected to grow to USD 200 million by 2032.
- Market to register a CAGR of around 5.23% during 2026-32.
- Category Shares
- Nrt gum grabbed market share of 35%.
- Competition
- More than 5 companies are actively engaged in producing nrt smoking cessation aids in Australia.
- Top 5 companies acquired around 95% of the market share.
- Perrigo Australia, Alphapharm Pty Ltd, Sigma Healthcare Ltd, Johnson & Johnson Pacific Pty Ltd, Dr Reddy's Laboratories (Australia) Pty Ltd etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 70% of the market.
Australia NRT Smoking Cessation Aids Market Outlook
The Australia NRT smoking cessation aids market size was valued at USD 140 million in 2025 and is projected to grow from USD 145 million in 2026 to USD 200 million by 2032, exhibiting a CAGR of around 5.23% during the forecast period. Growth is supported by the steady decline in smoking across the country and continued public health efforts encouraging quitting. According to the Australian Institute of Health and Welfare (AIHW), daily smoking among people aged 14 and over falls to 8.3% in 2022–2023, compared with 24.3% in 1991, while current smoking declines to 10.5% in 2024 from 11.7% in 2022. This long-term reduction in smoking behavior continues to sustain demand for cessation support products and structured quit programs.
Easy availability of quitting products also supports adoption. According to the government's advice, you can buy nicotine replacement therapy like NRT smoking cessation aids, i.e., patches, gums, sprays, inhalers, lozenges and tablets, to assist you in quitting smoking without seeing a doctor. By using popular places (shops or supermarkets) to purchase these products, it makes it easier for smokers who have intended to quit to do so. At the moment, most NRT products are still sold through physical retail channels; currently, online sales account for 30% of overall retail sales; thus providing smokers who require NRT with a great deal of convenience when they want to use one of these products to help them stop smoking.
However, alternative nicotine use is creating competition in quitting pathways. Government trend reports show current vaping peaks at 9.1% in 2023 and remains high at 8.2% in 2024, while overall vaping and/or smoking still accounts for 15.7% of Australians in 2024. Among younger nicotine users, vaping adoption is particularly strong, with 79% of users aged 14–24 and 66% aged 25–34 currently vaping. Such behaviour may hinder the process of total cessation, thus making NRT smoking cessation aids to compete more and more with cigarettes, as well as vaping and mixed nicotine use.
Product format preferences and expanding quit-support ecosystems continue shaping demand. NRT gum has the highest market share at 35%, due to its ability to be seamlessly integrated into everyday life and for its effectiveness at relieving sudden cravings after quitting. The government recommends utilising two types of NRT smoking cessation aids; for example, using both a patch in combination with an NRT gum or spray, will further enhance success of quitting. In addition to this, digital support platforms such as My QuitBuddy and The National Cessation Platform also offer alerting to use of both, tracking tool usage, as well as overall support; providing further evidence of a connection between digital support and assisted quitting solutions.

Australia NRT Smoking Cessation Aids Market Growth DriverQuitting Momentum Supports Product Demand
Australia’s smoking base keeps shrinking, but the need for quitting support remains strong. Australian Institute of Health and Welfare (AIHW) reports that daily smoking among people aged 14 and over stands at 8.3% , down from 24.3% in 1991. In parallel, the Australian Government’s 2025 smoking and vaping update shows current smoking among Australians aged 14+ declines to 10.5% in 2024 from 11.7% in 2022. This shows a clear national shift toward smoking reduction and quitting behavior.
This climate creates a need in nicotine replacement therapy (NRT) smoking cessation aids, since the desire to quit is aided by the easy access to products. According to the Australian Government, NRT is over-the-counter and available in pharmacies and selected supermarkets, and comes in the form of patches, gum, sprays, inhalers, lozenges, and tablets. These available formats remain a vital part of the quitting process as more smokers move beyond the awareness stage to action.
Australia NRT Smoking Cessation Aids Market ChallengeRising Vaping Use Creates a Competing Nicotine Path
A major challenge for NRT smoking cessation aids is that vaping remains a strong alternative nicotine pathway. The Australian Government’s 2025 trend report shows current vaping among Australians aged 14+ peaks at 9.1% in 2023 and remains high at 8.2% in 2024. Among nicotine users aged 14–24, 79% currently vape, while among those aged 25–34, 66% currently vape. This shows that a large share of nicotine users, especially younger adults, engage with vaping rather than traditional cessation products.
This creates pressure on NRT demand because some users stay within nicotine consumption instead of shifting fully to cessation aids. The same report shows overall current vaping and/or smoking still stands at 15.7% in 2024, even after easing from 17.0% in 2023. That suggests NRT brands compete not only with cigarettes, but also with vaping and mixed nicotine-use habits that can delay full quitting.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Australia NRT Smoking Cessation Aids Market TrendPharmacy-Centred Cessation Support Becomes More Visible
One of the market trends is the growing importance of pharmacies in the treatment of nicotine dependence. The Therapeutic Goods Administration (TGA) provides that, as of 1 July 2024, vapes that are aimed at smoking cessation or nicotine dependence can only be sold in participating pharmacies and not in other retail stores. It also states that, beginning 1 October 2024, pharmacists can dispense vapes with nicotine concentrations of 20 mg/mL or less to adults 18 years or older without a prescription, under the conditions and state or territory law.
This change pushes cessation support into more controlled and professional retail settings. The Australian Government confirms ongoing access to NRT products via pharmacy (in varying formats such as chewing gum, oral sprays, lozenges and transdermal patches) and through selected supermarkets; alternatively, by enabling the sale of NRT products in pharmacies, the Government creates a pharmacy led quitting ecosystem, where provision of regulated advice / access to products and nicotine dependence support will link more closely together.
Australia NRT Smoking Cessation Aids Market OpportunityDigital Quit Tools Expand Consumer Conversion Potential
A strong opportunity comes from Australia’s expanding digital quit-support network. The Australian Government states that My QuitBuddy is updated in late May 2025, following redevelopment funding, with a new design and added tracking features for people quitting smoking and vaping. The Government also says the National Cessation Platform at quit.org.au provides tools, resources and support mechanisms to help users quit. These platforms keep smokers engaged through daily reminders, progress tracking and structured support.
This creates room for NRT brands because digital support works well with assisted quitting. The Government’s current quit-support guidance states there is no one way to quit and that many people do best with a combination of methods. It also notes that using 2 forms of NRT such as a patch plus gum or spray can improve quit success. This makes digital-plus-NRT positioning a clear commercial opportunity within the category.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Australia NRT Smoking Cessation Aids Market Segmentation Analysis
By Category
- NRT Gum
- NRT Inhalators
- NRT Lozenges
- NRT Patches
- Other NRT Products
The segment has the highest share around product category with NRT gum holding 35%. Gum remains a leading format because it is simple to use and fits easily into daily life. The Australian Government states that NRT is available without prescription and comes in several forms, including gum, which supports its broad consumer acceptance in self-managed quit attempts.
Gum also benefits from its role in combination quitting. The Government states that using 2 forms of NRT, a slow release option such as a patch and a short-release option such as gum or spray-can improve quit success. This keeps gum highly relevant because it helps users handle sudden cravings while fitting into wider quit routines and pharmacist-guided cessation plans.

By Sales Channel
- Retail Online
- Online Pharmacies
- Brand-Owned Websites
- E-commerce Marketplaces
- Retail Offline
- Hospital
- Pharmacies
- Drug Stores
The segment has the highest share around segment under the sales channel, with retail offline holding 70%. This leadership fits Australia’s regulated cessation environment. The Australian Government states that NRT products are available without prescription from pharmacies and some supermarkets, which keeps physical retail highly important for visibility, immediate purchase and consumer trust.
Offline retail also gains strength from pharmacy-led nicotine support. The TGA states that vapes for smoking cessation can only be sold through participating pharmacies from 1 July 2024, and from 1 October 2024 pharmacists may supply certain low-nicotine vapes to adults 18+ without a prescription under set conditions. This keeps pharmacies central to nicotine-dependence management and supports the strong position of offline retail in the category.
List of Companies Covered in Australia NRT Smoking Cessation Aids Market
The companies listed below are highly influential in the Australia nrt smoking cessation aids market, with a significant market share and a strong impact on industry developments.
- Perrigo Australia
- Alphapharm Pty Ltd
- Sigma Healthcare Ltd
- Johnson & Johnson Pacific Pty Ltd
- Dr Reddy's Laboratories (Australia) Pty Ltd
Competitive Landscape
In 2025, the Australian NRT smoking cessation aids market remains dominated by Johnson & Johnson Pacific Pty Ltd, with its Nicorette brand leading in value share at 57.1%, supported by a diverse product portfolio and strong retail presence. Following in second place is Dr Reddy's Laboratories (Australia) Pty Ltd, which strengthened its position through the acquisition of Haleon’s divested NRT portfolio, including Nicabate, benefiting from established brand equity and distribution networks, capturing 21.9% of the market. Perrigo Australia ranks third, appealing to price-sensitive consumers with affordable generics, while the remainder of the market is fragmented. Pharmacies continue to be the key distribution channel, representing 70% of sales, a position reinforced by recent vaping reforms that restricted access to therapeutic and disposable vapes. Overall, the market is shaped by declining smoking rates, government-led cessation initiatives, rising vaping alternatives, and strategic acquisitions that consolidate competitive positions.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Australia NRT Smoking Cessation Aids Market Policies, Regulations, and Standards
- Australia NRT Smoking Cessation Aids Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Australia NRT Smoking Cessation Aids Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Category
- NRT Gum- Market Insights and Forecast 2022-2032, USD Million
- NRT Inhalators- Market Insights and Forecast 2022-2032, USD Million
- NRT Lozenges- Market Insights and Forecast 2022-2032, USD Million
- NRT Patches- Market Insights and Forecast 2022-2032, USD Million
- Other NRT Products- Market Insights and Forecast 2022-2032, USD Million
- By Gender
- Male- Market Insights and Forecast 2022-2032, USD Million
- Female- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Brand-Owned Websites- Market Insights and Forecast 2022-2032, USD Million
- E-commerce Marketplaces- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Hospital- Market Insights and Forecast 2022-2032, USD Million
- Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Drug Stores- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Individual / Consumer Self-Use- Market Insights and Forecast 2022-2032, USD Million
- Healthcare-Professional-Supervised- Market Insights and Forecast 2022-2032, USD Million
- Clinics- Market Insights and Forecast 2022-2032, USD Million
- De-addiction Centers - Market Insights and Forecast 2022-2032, USD Million
- Smoking Cessation Centers- Market Insights and Forecast 2022-2032, USD Million
- By Region
- Queensland
- New South Wales
- Victoria
- South Australia
- Others
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Category
- Market Size & Growth Outlook
- Australia NRT Gum Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Gender- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Australia NRT Inhalators Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Gender- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Australia NRT Lozenges Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Gender- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Australia NRT Patches Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Gender- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Australia Other NRT Products Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Gender- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Johnson & Johnson Pacific Pty Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Dr Reddy's Laboratories (Australia) Pty Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Perrigo Australia
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Alphapharm Pty Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sigma Healthcare Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Haleon Australia Pty Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GSK Consumer Healthcare
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sigma Pharmaceuticals Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Others
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Johnson & Johnson Pacific Pty Ltd
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Category |
|
| By Gender |
|
| By Sales Channel |
|
| By End User |
|
| By Region |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











